The abstract is read at the publisher; the summary is JClub's.
ADM2 is selectively upregulated in a highly invasive cancer-cell subpopulation near blood vessels and is required for intratumoral invasion, intravasation, and metastasis.
- Why it matters: Intravasation depends on both directed invasion and access to functional vascular intravasation sites, but the regulators of tumor–vessel interactions are not well defined.
- What they did: Using intravital video microscopy, the study tested ADM2 via knockdown in a chicken embryo metastasis model and in vitro, and via ADM2 targeting in a mouse metastasis model.
- The result: ADM2 loss impaired invasion and intravasation, reduced vascularization and competent intravasation sites, and suppressed invasive metastatic lesion formation; ADM2 targeting in mice inhibited large intratumoral blood vessel development and reduced metastasis.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.